M K Proteins Latest Share Price (MKPL)
TODAY IN ONE LINE
MKPL edged up 0.5% on light volume, in line with Nifty's -0.1% move.
With a market cap of ₹155.78 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
M K Proteins flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 74.8% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 54.9% YoY
- ●Poor Capital ReturnsLow ROE of 9.4%
- ●Rising Receivables vs SalesReceivables grew 83.8% outpacing sales growth of 9.0%
Latest M K Proteins News
What changed recently?
Recent events, corporate actions, and announcements.
M K Proteins Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for M K Proteins Limited, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
M K Proteins Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for M K Proteins Limited — derived from the latest tape, not yesterday's close.
M K Proteins Limited last traded at ₹4.15 with an intraday range of ₹4–₹4.18 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹4.15| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 4.58 | +0.43 | +10.36% |
| R3 | 4.40 | +0.25 | +6.02% |
| R2 | 4.29 | +0.14 | +3.37% |
| R1 | 4.22 | +0.07 | +1.69% |
| PIVOT | 4.11 | -0.04 | -0.96% |
| CURRENT | 4.15 | — | — |
| S1 | 4.04 | -0.11 | -2.65% |
| S2 | 3.93 | -0.22 | -5.30% |
| S3 | 3.86 | -0.29 | -6.99% |
| S4 | 3.68 | -0.47 | -11.33% |
MKPL is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹4.11–₹4.16
Trading Inside opening range
M K Proteins Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for M K Proteins Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
M K Proteins Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹155.78 Cr. and reported EPS of ₹0.18.
M K Proteins segment analysis : revenue and profit mix.
Disclosed business segments at M K Proteins with their share of revenue and profit, switchable between consolidated and standalone reporting.
M K Proteins discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for M K Proteins Limited.
Our AI distills the core fundamental drivers supporting M K Proteins Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
M K Proteins Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
High promoter holding 74.82% signals strong management commitment and shareholder alignment.
Quarterly sales surged 6.37% YoY to ₹146 Cr, demonstrating robust underlying market demand.
Latest quarterly PAT up 41.5% YoY, reflecting operational efficiency improvements despite headwinds.
Low debt-to-equity ratio 0.49x ensures financial flexibility and moderate leverage profile.
Vertical integration of by-products maximizes resource utilization and revenue diversification.
Key Risks.
Latest quarterly EPS declined 59.3% YoY despite revenue growth, signaling severe earnings volatility.
TTM EPS declined 54.9% YoY to ₹0.18, reflecting sustained profitability pressure.
Operating margin compressed to 2.87% in FY26 from 4.60% in FY25, indicating margin erosion.
P/E 27.33x exceeds sector median ~24.7x, suggesting overvaluation relative to fundamentals.
Zero dividend yield limits income appeal for conservative and dividend-seeking investors.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
M K Proteins Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — M K Proteins Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
M K Proteins Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for M K Proteins Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
M K Proteins Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for M K Proteins Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in M K Proteins Limited stood at 71.2% of traded volume, against a 20-day average of 73.3%.
M K Proteins announcements: results, concalls, ratings, M&A.
Filings M K Proteins sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
M K Proteins files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 47 documents below.
Copy of Newspaper Publication
M K Proteins Limited has informed the Exchange about Copy of Newspaper publications in the Financial Express (English Edition) and Jansatta (Hindi…
Outcome of Board Meeting
M K Proteins Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026 approvaed by the Board of Directors of…
Resignation of Director/KMP/SMP
M K Proteins Limited has informed the Exchange about Resignation of Director/KMP/SMP
Resignation of Director/KMP/SMP
M K Proteins Limited has informed the Exchange about Resignation of Director/KMP/SMP
Resignation of Director/KMP/SMP
M K Proteins Limited has informed the Exchange about Resignation of Director/KMP/SMP
M K Proteins dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue M K Proteins has declared, sequenced by announce and record date.
M K Proteins corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About M K Proteins Limited: business, sector, key facts.
What M K Proteins Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
M K Proteins Limited operates in the Edible Oil industry under the Fast Moving Consumer Goods sector, listed as NSE: MKPL, BSE: 543919.
M. K. Proteins Limited (MKPL) is primarily engaged in the manufacturing and trading of vegetable refined oils and their associated by-products. Their operations span a wide range of vegetable oils, including rice bran, sunflower, cottonseed, soybean, palm, and canola oils. The company's core business revolves around processing these oils into refined products suitable for various applications, from culinary use to industrial purposes.
A significant aspect of MKPL's business model is the utilization of oil by-products. Instead of discarding these materials, the company processes them into valuable secondary products. This includes extracting and selling rice bran fatty acid oils, rice bran waxes, gums, and spent earth. This vertical integration strategy maximizes resource utilization and contributes to a more efficient and sustainable business operation.
Beyond its refining and processing capabilities, MKPL also plays a crucial role in the import and trade of crude oils. This involvement in the global oil market allows the company to secure raw materials and manage its supply chain effectively. The company's trading activities extend to both edible and non-edible oils, further diversifying its revenue streams and market reach.
In summary, MKPL's business encompasses the entire value chain from sourcing crude oils to refining them, creating valuable by-products, and finally, trading both refined and crude oils in the market. This integrated approach to oil processing and trading positions the company within a robust and diversified market segment within India’s edible oil industry. The company’s focus on utilizing by-products also demonstrates an understanding of sustainable practices and resource management. Established in 2012 and headquartered in Ambala, India, MKPL has carved a niche for itself in the Indian vegetable oil market.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AWL Agri Business (AWL) Share PricePeer
- Gokul Refoils and Solvent (GOKUL) Share PricePeer
- Gokul Agro Resources (GOKULAGRO) Share PricePeer
- Kriti Nutrients (KRITINUT) Share PricePeer
- Marico (MARICO) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about M K Proteins Limited (MKPL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of M K Proteins Limited (MKPL)?
The current share price of M K Proteins Limited (MKPL) is ₹4.15. Today, the stock has gained by ₹0.02 (0.48%), trading in a range of ₹4.00 to ₹4.18. The stock opened at ₹4.16 with a trading volume of 61,287 shares.
02Is M K Proteins Limited stock a good investment for long-term?
M K Proteins Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹155.78 Cr., P/E ratio of 0, ROE of 9.37%, and ROCE of 10.1%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of M K Proteins Limited stock?
The 52-week high price of M K Proteins Limited (MKPL) is ₹8.85, while the 52-week low is ₹3.56. Currently trading at ₹4.15, the stock is 16.57% above its 52-week low and 53.11% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy M K Proteins Limited stock at the current price?
Whether to buy M K Proteins Limited stock at ₹4.15 depends on multiple factors. The stock is currently trading with a P/E ratio of 0 and P/B ratio of 0. Today's performance shows a gain of 0.48%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of M K Proteins Limited and when is the next dividend?
M K Proteins Limited offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹4.15, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of M K Proteins Limited?
M K Proteins Limited's key financial metrics include: P/E Ratio: 0, P/B Ratio: 0, ROE: 9.37%, ROCE: 10.1%, Dividend Yield: 0%, EPS: ₹0.18, Book Value: ₹2.01, and Debt-to-Equity: 0.49. The company's market cap stands at ₹155.78 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is M K Proteins Limited stock performing today in the market?
M K Proteins Limited stock opened at ₹4.16 and is currently trading at ₹4.15, showing a gain of ₹0.02 (0.48%). The intraday high is ₹4.18 and low is ₹4.00. The trading volume stands at 61,287 shares, indicating moderate market participation today.
08What is the P/E ratio of M K Proteins Limited and what does it indicate?
M K Proteins Limited has a Price-to-Earnings (P/E) ratio of 0, which means investors are willing to pay 0.00 for every ₹1 of earnings. With an EPS of ₹0.18, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about M K Proteins Limited (MKPL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.